Core Laboratories Inc. (CLB) Cash Flow Statement
Core Laboratories Inc. (CLB) generated $28.2M of operating cash flow over the twelve months to 2026-06-30, spent $17.3M on capital expenditure and had free cash flow of $10.9M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLBCore Laboratories Inc.Follow CLB — free
—
Price chart with a free account
- Market cap
- 454.7M
- P/E TTM
- 19.1
- Dividend yield
- 0.4%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Operating cash flow | 24.8 | 56.4 | 37.0 | 28.2 | |
| Capital expenditure | 10.6 | 13.0 | 14.6 | -17.3 | |
| Free cash flow | 14.2 | 43.4 | 22.4 | 10.9 | |
| Dividends paid | 1.9 | 1.9 | 1.9 | — | |
| Share repurchases | 2.2 | 5.3 | 12.4 | — | |
| Stock-based compensation | 14.0 | 3.8 | 7.1 | — |
USD millions · SEC XBRL
Core Laboratories Inc. — questions
- What is Core Laboratories Inc.'s operating cash flow?
- $28.2M over the twelve months to 2026-06-30.
- How much does Core Laboratories Inc. spend on capital expenditure?
- $17.3M over the twelve months to 2026-06-30.
- What is Core Laboratories Inc.'s free cash flow?
- $10.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Core Laboratories Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.